Australian Broker Call *Extra* Edition – Sep 06, 2023

This story features ADBRI LIMITED, and other companies. For more info SHARE ANALYSIS: ABC

An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities.

In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.

One key difference is the *Extra* Edition will not be updated daily, but merely "regularly" depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.

Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena's team of journalists.

Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.

The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.

The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.

COMPANIES DISCUSSED IN THIS ISSUE

Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)

ABC   AIZ   AND   CCX   CU6   GDC   HLO   IDX   IMD   LFG   LYC   MIN  

ABC    ADBRI LIMITED

Building Products & Services – Overnight Price: $2.18

Goldman Sachs rates ((ABC)) as Neutral (3) –

Adbri's H1 underlying profit was a 2% beat against forecasts from Goldman Sachs and consensus, while underlying earnings (EBIT) were a -2% miss against consensus.

Higher-than-expected revenues were driven by higher price/mix across product categories, albeit with higher-than-anticipated costs, but leading to a 6% earnings (EBITDA) beat against the broker.

Management expects H2 underlying earnings will be moderately higher than H1 and anticipates demand will remain strong, with trading conditions in-line with H1.

The broker's target rises to $1.85 from $1.65. Neutral.

This report was published on August 30, 2023.

Target price is $1.85 Current Price is $2.18 Difference: minus $0.33 (current price is over target).
If ABC meets the Goldman Sachs target it will return approximately minus 15% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $2.17, suggesting downside of -0.5%(ex-dividends)
The company's fiscal year ends in December.

Forecast for FY23:

Goldman Sachs forecasts a full year FY23 dividend of 9.00 cents and EPS of 16.00 cents.
At the last closing share price the estimated dividend yield is 4.13%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.63.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 16.1, implying annual growth of 2.4%.
Current consensus DPS estimate is 1.8, implying a prospective dividend yield of 0.8%.
Current consensus EPS estimate suggests the PER is 13.5.

Forecast for FY24:

Goldman Sachs forecasts a full year FY24 dividend of 10.00 cents and EPS of 15.00 cents.
At the last closing share price the estimated dividend yield is 4.59%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.53.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 15.6, implying annual growth of -3.1%.
Current consensus DPS estimate is 6.2, implying a prospective dividend yield of 2.8%.
Current consensus EPS estimate suggests the PER is 14.0.

Market Sentiment: -0.6
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

AIZ    AIR NEW ZEALAND LIMITED

Transportation & Logistics – Overnight Price: $0.77

Jarden rates ((AIZ)) as Overweight (2) –

Jarden assesses a solid FY23 result for Air New Zealand with in-line underlying profit (PBT) compared to forecasts by the broker and consensus.

Elevated yields (45% higher than FY19) outweighed elevated cost inflation, explain the analysts, with group cost-per-available-seat kilometer (CASK) around 40% higher than the previous corresponding period.

Dividends were reinstated with the declaration of a 6cps final dividend and management updated its capital management policy to include a target payout ratio of 40-70% of underlying profit (NPAT).

Jarden feels market share and pricing are likely to remain supportive in the 1H of FY24, with yields holding near current levels on most routes.

The broker's target is lowered to NZ$0.79 from NZ$0.90. Overweight.

This report was published on August 29, 2023.

Current Price is $0.77. Target price not assessed.
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 4.51 cents and EPS of 8.28 cents.
At the last closing share price the estimated dividend yield is 5.89%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.24.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 4.51 cents and EPS of 8.10 cents.
At the last closing share price the estimated dividend yield is 5.89%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.45.

This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

AND    ANSARADA GROUP LIMITED

Software & Services – Overnight Price: $1.35

Moelis rates ((AND)) as Buy (1) –

To reflect a strong exit run rate, evident in FY23 results, Moelis lifts its FY24 earnings (EBITDA) forecast by $3.9m to $12m. As a result, the target rises to $2.00 from $1.76.

The company delivered strong quarter-on-quarter growth for both operating cash flow and earnings after reducing costs in the 1Q of FY23 in reaction to a decline in market deal activity.

For FY24, Moelis assumes gradual improvement in M&A deal volumes and ongoing growth across procurement (government tenders), insolvencies, debt refinances and the governance, risk and compliance (GRC) segment.

The Buy rating is maintained.

This report was published on August 31, 2023.

Target price is $2.00 Current Price is $1.35 Difference: $0.65
If AND meets the Moelis target it will return approximately 48% (excluding dividends, fees and charges).
The company's fiscal year ends in June.

Forecast for FY24:

Moelis forecasts a full year FY24 dividend of 0.00 cents and EPS of 0.10 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 1350.00.

Forecast for FY25:

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

CCX    CITY CHIC COLLECTIVE LIMITED

Apparel & Footwear – Overnight Price: $0.43

Wilsons rates ((CCX)) as Downgrade to Underweight from Market Weight (5) –

City Chic Collective's FY23 result sharply missed Wilsons's forecasts, due to big misses on gross profits, gross margins and operational expenditure. Sales were a slight beat and cash flow improved. 

Inventory fell but was accompanied by discounting, and the company logged a provision.

The company finished the year with net cash of $10.9m.

Wilsons observes management's trading update for the first months of FY24 to be weaker than the broker had forecast, and that private equity opportunities have evaporated following the company's own restructure.

Rating is downgraded to Underweight from Market Weight, the broker considering the company's gross margin targets to be ambitious. Target price inches up to 37c from 36c. EPS forecasts fall sharply.

This report was published on August 31, 2023.

Target price is $0.37 Current Price is $0.43 Difference: minus $0.06 (current price is over target).
If CCX meets the Wilsons target it will return approximately minus 14% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $0.51, suggesting upside of 17.7%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Wilsons forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 14.60 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 2.95.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is -3.5, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.

Forecast for FY25:

Wilsons forecasts a full year FY25 dividend of 0.00 cents and EPS of 0.70 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 61.43.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 3.4, implying annual growth of N/A.
Current consensus DPS estimate is 0.8, implying a prospective dividend yield of 1.9%.
Current consensus EPS estimate suggests the PER is 12.6.

Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

CU6    CLARITY PHARMACEUTICALS LIMITED

Medical Equipment & Devices – Overnight Price: $1.00

Wilsons rates ((CU6)) as Overweight (1) –

Wilsons observes that Clarity Pharmaceuticals is progressing faster than scheduled to get two prostate cancer diagnostic products (superior to current radiopharmaceutical offerings) to market.

Add to that the logistical benefits of copper and NorthStart's commercial supply of coper being set for June, the broker suspects the company may gain greater market share than previously thought and spies a derisking in FY24 (although FY24 EPS losses are extended).

Overweight rating retained. Target price rises to $1.55 from $1.22.

This report was published on August 31, 2023.

Target price is $1.55 Current Price is $1.00 Difference: $0.545
If CU6 meets the Wilsons target it will return approximately 54% (excluding dividends, fees and charges).
The company's fiscal year ends in June.

Forecast for FY24:

Wilsons forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 13.80 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 7.28.

Forecast for FY25:

Wilsons forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 17.40 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 5.78.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

GDC    GLOBAL DATA CENTRE GROUP

Cloud services – Overnight Price: $1.73

Moelis rates ((GDC)) as Buy (1) –

Global Data Centre offers compelling value on a sum-of-the-parts (SOTP) valuation basis, according to Moelis, trading at an around -30% discount to net asset value (NAV).

These broker comments follow FY23 results which revealed a 66% rise in earnings (EBITDA) over the previous corresponding period, 8% higher than the analyst's forecast..

While FY23 results showed the company's Airtrunk stake was revalued to $45m from $35m, Moelis suggests its SOTP valuation may understate Airtrunk's carrying value.

The broker highlights a significant FY23 scale-up to the ETIX built capacity to 6MW from 4.1MW via acquisitions in France and brownfield expansion in Bangkok.

The target rises to $2.37 from $2.03. Management is investigating asset-level monetisation, which Moelis suggests provides a medium-term pathway for realising value. Buy.

This report was published on August 31, 2023.

Target price is $2.37 Current Price is $1.73 Difference: $0.645
If GDC meets the Moelis target it will return approximately 37% (excluding dividends, fees and charges).
The company's fiscal year ends in June.

Forecast for FY24:

Moelis forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 3.70 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 46.62.

Forecast for FY25:

Moelis forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 1.30 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 132.69.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

HLO    HELLOWORLD TRAVEL LIMITED

Travel, Leisure & Tourism – Overnight Price: $3.06

Jarden rates ((HLO)) as Overweight (2) –

While FY23 results for Helloworld Travel were strong, they contained no surprises for Jarden given they were largely pre-announced.

FY24 earnings (EBITDA) guidance in the range of $64-72m was a beat against the consensus estimate and a touch below the broker's forecast.

Jarden tempers its FY24 and FY25 EPS forecasts to reflect guidance, but raises its total transaction value (TTV) estimates by 5% to reflect a solid run-rate and ongoing strong leisure demand. A cut to revenue margins is offset by a lower cost-of-doing-business (CODB) forecast.

The target rises to $4.05 from $3.75. Overweight.

This report was published on August 29, 2023.

Target price is $4.05 Current Price is $3.06 Difference: $0.99
If HLO meets the Jarden target it will return approximately 32% (excluding dividends, fees and charges).
Current consensus price target is $3.68, suggesting upside of 20.2%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 EPS of 23.30 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.13.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 19.0, implying annual growth of 69.5%.
Current consensus DPS estimate is 9.6, implying a prospective dividend yield of 3.1%.
Current consensus EPS estimate suggests the PER is 16.1.

Forecast for FY25:

Jarden forecasts a full year FY25 EPS of 28.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 10.93.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 27.1, implying annual growth of 42.6%.
Current consensus DPS estimate is 13.2, implying a prospective dividend yield of 4.3%.
Current consensus EPS estimate suggests the PER is 11.3.

Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

IDX    INTEGRAL DIAGNOSTICS LIMITED

Medical Equipment & Devices – Overnight Price: $3.02

Jarden rates ((IDX)) as Overweight (2) –

Organic revenue growth in the 2H was a step-up from the 1H in both Australia and New Zealand, prompting Jarden to suggest Integral Diagnostics had turned the corner in FY23. Due to a fall in net debt in the 2H, fears of a capital raise have eased.

Management met the qualitative 2H FY23 guidance of a "materially stronger" second half for earnings (EBITDA), and in the process beat forecasts by the analysts and consensus by 2.6% and 0.6%, respectively.

As inflationary pressures ease, the broker anticipates additional longer-term fixed cost leverage opportunities. The target rises to $3.23 from $3.11 and the Overweight rating is unchanged.

This report was published on August 29, 2023.

Target price is $3.23 Current Price is $3.02 Difference: $0.21
If IDX meets the Jarden target it will return approximately 7% (excluding dividends, fees and charges).
Current consensus price target is $3.21, suggesting upside of 6.4%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 7.00 cents and EPS of 12.90 cents.
At the last closing share price the estimated dividend yield is 2.32%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 23.41.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 12.0, implying annual growth of 11.5%.
Current consensus DPS estimate is 8.9, implying a prospective dividend yield of 2.9%.
Current consensus EPS estimate suggests the PER is 25.2.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 8.10 cents and EPS of 16.20 cents.
At the last closing share price the estimated dividend yield is 2.68%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.64.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 15.8, implying annual growth of 31.7%.
Current consensus DPS estimate is 12.0, implying a prospective dividend yield of 4.0%.
Current consensus EPS estimate suggests the PER is 19.1.

Market Sentiment: 0.1
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

IMD    IMDEX LIMITED

Mining Sector Contracting – Overnight Price: $1.73

Jarden rates ((IMD)) as Overweight (2) –

FY23 results for Imdex were weaker than Jarden expected due mainly to 2H weakness as exploration spend softened in Australia and Canada and the revenue mix shifted towards lower margin products relative to services.

While a ramp-up in R&D and corporate costs also weighed on profitability, the analysts expect these investments will generate returns over the near term.

Management provided no qualitative guidance but expects conditions to stabilise through FY24, most likely in the 2H.

The broker earnings forecasts are lowered by around -3% across the forecast period and profit forecasts suffer to a greater extent after integrating the Devico acquisition into estimates.

The target falls to $2.05 from $2.15. Overweight.

This report was published on August 29, 2023.

Target price is $2.05 Current Price is $1.73 Difference: $0.32
If IMD meets the Jarden target it will return approximately 18% (excluding dividends, fees and charges).
Current consensus price target is $1.96, suggesting upside of 13.4%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 3.40 cents and EPS of 10.50 cents.
At the last closing share price the estimated dividend yield is 1.97%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.48.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 12.2, implying annual growth of 53.5%.
Current consensus DPS estimate is 3.9, implying a prospective dividend yield of 2.3%.
Current consensus EPS estimate suggests the PER is 14.2.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 4.10 cents and EPS of 12.70 cents.
At the last closing share price the estimated dividend yield is 2.37%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.62.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 12.4, implying annual growth of 1.6%.
Current consensus DPS estimate is 3.7, implying a prospective dividend yield of 2.1%.
Current consensus EPS estimate suggests the PER is 14.0.

Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

LFG    LIBERTY FINANCIAL GROUP LIMITED

Diversified Financials – Overnight Price: $3.80

Jarden rates ((LFG)) as Neutral (3) –

FY23 reported profit for Liberty Financial fell by -17% year-on-year, impacted by a sharp fall in margin and normalisation of bad and doubtful debts (BDDs), partly offset by resilient book growth, explains Jarden. The 24cps final dividend was in line with expectation.

Management is performing well in a tough environment, and the broker sees positive signs including a stabilisation of new mortgage flows and sound cost control.

The target eases to $3.90 from $4.00 and the Neutral rating is maintained as Liberty Financial is relatively overvalued when compared to its peers.

This report was published on August 29, 2023.

Target price is $3.90 Current Price is $3.80 Difference: $0.1
If LFG meets the Jarden target it will return approximately 3% (excluding dividends, fees and charges).
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 29.00 cents and EPS of 46.40 cents.
At the last closing share price the estimated dividend yield is 7.63%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.19.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 32.00 cents and EPS of 51.20 cents.
At the last closing share price the estimated dividend yield is 8.42%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 7.42.

Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

LYC    LYNAS RARE EARTHS LIMITED

Rare Earth Minerals – Overnight Price: $7.36

Goldman Sachs rates ((LYC)) as Neutral (3) –

FY23 underlying earnings (EBITDA) for Lynas Rare Earths beat both consensus and Goldman Sachs forecasts by 4% due to a currency gain and higher interest income on the $1bn cash balance.

Management also revised up capex guidance to $780m from $575m for the Kalgoorlie Cracking & Leaching facility due to inflation and project delays. The capex estimate for the Mt Weld expansion is also under review.

The company also provided designed nameplate production for the Kalgoorrlie C&L facility of 9ktpa of NdPr.

An upsized 2025 target to 12ktpa NdPr implies doubling of production but at higher capex of around -$1.6bn, on Goldman Sachs estimates.

The target price slips to $6.50 from $6.60. Neutral.

This report was published on August 30, 2023.

Target price is $6.50 Current Price is $7.36 Difference: minus $0.86 (current price is over target).
If LYC meets the Goldman Sachs target it will return approximately minus 12% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $7.65, suggesting upside of 3.9%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Goldman Sachs forecasts a full year FY24 dividend of 4.00 cents and EPS of 23.30 cents.
At the last closing share price the estimated dividend yield is 0.54%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 31.59.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 33.6, implying annual growth of -1.3%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 21.9.

Forecast for FY25:

Goldman Sachs forecasts a full year FY25 dividend of 22.00 cents and EPS of 40.00 cents.
At the last closing share price the estimated dividend yield is 2.99%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.40.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 41.5, implying annual growth of 23.5%.
Current consensus DPS estimate is 0.3, implying a prospective dividend yield of 0.0%.
Current consensus EPS estimate suggests the PER is 17.7.

Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

MIN    MINERAL RESOURCES LIMITED

Iron Ore – Overnight Price: $73.45

Goldman Sachs rates ((MIN)) as Sell (5) –

Mineral Resources' FY23 divisional earnings were broadly in-line with Goldman Sachs forecasts for iron ore and mining services but slightly below for lithium.

Overall FY23 profit was a 5% beat compared to the analyst's estimate due to lower-than-expected net interest and D&A expenses. The 70cps final dividend exceeded the broker's 46cps estimate.

The broker suggests FY24 is a transitional year operationally as management invests for growth. While project timelines appear to be on track, FY24 guidance disappointed on higher-than-expected costs for lithium and iron ore.

Also, guidance for lithium production was lower than Goldman Sachs forecast and implies flat lithium spodumene production in 1H of FY24 for both Mt Marion and Wodgina before a step-up in early 2024.

The target falls to $53 from $56. Sell.

This report was published on August 30, 2023.

Target price is $53.00 Current Price is $73.45 Difference: minus $20.45 (current price is over target).
If MIN meets the Goldman Sachs target it will return approximately minus 28% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $78.00, suggesting upside of 6.2%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Goldman Sachs forecasts a full year FY24 EPS of 292.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 25.15.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 445.9, implying annual growth of 250.1%.
Current consensus DPS estimate is 188.1, implying a prospective dividend yield of 2.6%.
Current consensus EPS estimate suggests the PER is 16.5.

Forecast for FY25:

Goldman Sachs forecasts a full year FY25 EPS of minus 20.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 367.25.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 850.3, implying annual growth of 90.7%.
Current consensus DPS estimate is 378.7, implying a prospective dividend yield of 5.2%.
Current consensus EPS estimate suggests the PER is 8.6.

Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

---

Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don't have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide experienced, intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface.

This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.

Decisions about inclusions in this Report are made independently of the providers of stock market research and at full discretion of the team of journalists responsible for content at FNArena. Inclusion does not equal endorsement, in any way, shape or form. This Report is provided for informational purposes only.

Click to view our Glossary of Financial Terms